Evidence map›Paper›PMID 39562017›Full record

ArticleBMJ (Clinical research ed.)2024

Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation.

Elie A Akl, Joanne Khabsa, Claire Iannizzi, Vanessa Piechotta, Lara A Kahale, James M Barker, Joanne E McKenzie, Matthew J Page, Nicole Skoetz, PRISMA-LSR Group

Abstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Exploring the clinical effects ofFrontiers in pharmacology · 2025
    Pooled it
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elie A AklDepartment of Internal Medicine, American University of Beirut, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-3444-8618
Joanne KhabsaClinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.
Claire IannizziInstitute of Public Health, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Vanessa PiechottaImmunization Unit, Department of Infectious Disease Epidemiology, Robert Koch-Institut, Berlin, Germany.
Lara A KahaleInfectious Disease Society of America, Arlington, VA, USA.
James M BarkerF1000 Research, London, UK.
Joanne E McKenzieMethods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Matthew J PageMethods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Nicole SkoetzInstitute of Public Health, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
PRISMA-LSR Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39562017
PMCPMC12036629

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.